Levitas Bio LeviCell EOS System
Levitas Bio has launched the LeviCell EOS System the next generation of its platform for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells. Using the company's "levitation" technology, researchers can scale their experiments up to 16x (through up to four interconnected LeviCell ROS modules) and process up to 40 million cells per run. An embedded thermal control system allows users to select from a range of pre-defined temperatures, ensuring samples are processed at ideal temperatures to maintain cellular states; while a fully reticulated imaging system enables real-time sample characterization analytics during processing, enabling insights such as fractionation, cell counts, viability assessment, and quality measurements, Levitas said.
The company is debuting the platform alongside its new LeviPrep and LeviSelect product lines for tissue dissociation and targeted cellular selection at the upcoming American Association for Cancer Research annual meeting.